Analysis of level A in vitro–in vivo correlations for an extended‐release formulation with limited bioavailability
Open Access
- 24 October 2012
- journal article
- research article
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 34 (5) , 262-277
Abstract
A two‐stage, numerical deconvolution approach was employed to develop level A in vitro–in vivo correlations using data for three formulations of an extended‐release oral dosage form. The in vitro dissolution data for all formulations exhibited near‐complete dissolution within the time frame of the test. The pharmacokinetic concentration–time profiles for 16 subjects in a cross‐over study demonstrated notably limited bioavailability for the slowest formulation. These data were used as the basis for the IVIVC model development. Two models were identified that satisfied the nominal requirements for a conclusive internal predictability of the IVIVC, provided that all three formulations were used as internal datasets. These were a simple linear model with absorption cut‐off and a piecewise‐linear variable absorption scale model. A subsequent cross‐validation of the models' robustness indicated that neither model predicted satisfactorily the pharmacokinetic characteristics of all formulations in a conclusive manner. The piecewise‐linear variable absorption scale model provided the most accurate results, particularly with respect to the prediction of the slowest formulation's pharmacokinetic metrics. But this latter model also involved additional free parameters compared with the simple linear model with absorption cut‐off. It is argued that more complex IVIVC models with extra parameterization require comprehensive validation to ascertain the accuracy and robustness of the model. In order to achieve this, it is necessary to ensure a complete suite of supporting datasets for internal and external validation, irrespective of the mathematical approach used subsequently to develop the IVIVC. Copyright © 2013 John Wiley & Sons, Ltd.Keywords
This publication has 14 references indexed in Scilit:
- A nonlinear mixed effects IVIVC model for multi-release drug delivery systemsJournal of Pharmacokinetics and Pharmacodynamics, 2008
- In Vitro–In Vivo Correlation: Importance of Dissolution in IVIVCDissolution Technologies, 2007
- Deconvolution Based Approach for Level A In Vivo-In Vitro Correlation Modelling: Statistical ConsiderationsClinical Research and Regulatory Affairs, 2005
- Interpretation and Optimization of the Dissolution Specifications for a Modified Release Product with an In Vivo–In Vitro Correlation (IVIVC)Journal of Pharmaceutical Sciences, 2004
- Direct, differential-equation-based in-vitro–in-vivo correlation (IVIVC) methodJournal of Pharmacy and Pharmacology, 2003
- IVIVR versus IVIVCDissolution Technologies, 2000
- Level A in Vivo−in Vitro Correlation: Nonlinear Models and Statistical MethodologyJournal of Pharmaceutical Sciences, 1997
- Convolution-Based Approaches for in Vivo-in Vitro Correlation Modeling1997
- In vitro/in vivo correlations: Scientific implications and standardisationEuropean Journal of Drug Metabolism and Pharmacokinetics, 1993
- In Vitro-ln Vivo Correlation for Modified-Release FormulationsJournal of Pharmaceutical Sciences, 1993